• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-08-24

  Learn how to use hypersensitive HRP chemiluminescence for low-abundance Western blot targets, including pathway proteins in metabolic disease models. This workflow combines practical exposure planning, membrane-specific optimization, and troubleshooting for reliable signal with diluted antibodies.

• Bradford Protein Assay Kit: Practical Guide

  2026-08-24

  The Bradford Protein Assay Kit provides a rapid colorimetric method for protein concentration measurement when sample volume and turnaround time are limited. It is suitable for routine biochemical protein assay workflows, but samples outside the stated range or containing potentially interfering formulation components require dilution, controls, or an alternative method.

• Dual-Action Inhibitors Reprogram p38α Dephosphorylation

  2026-08-23

  The reference study shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can also accelerate WIP1-mediated removal of the activation-loop phosphate. Structural and biochemical experiments link this dual action to an inhibitor-stabilized p38α conformation that exposes the phospho-threonine, suggesting a strategy for improving the depth and specificity of kinase pathway inhibition.

• Carvacrol: Redox, Cell Cycle, and Apoptosis

  2026-08-22

  Carvacrol, also called 5-isopropyl-2-methylphenol, is a monoterpene phenol used in redox, TRP-channel, cell cycle, and apoptosis research. Evidence supports its value as a non-electrophilic TRPA1 agonist and as a defined chemical tool, but channel responses to singlet oxygen or hydrogen peroxide should not be generalized to anticancer efficacy.

• G007-LK Tankyrase 1/2 Inhibitor Workflow

  2026-08-22

  G007-LK enables selective tankyrase 1/2 inhibition across reporter, degradation, proliferation, and tumor-model workflows. This guide connects practical assay design with Wnt/β-catenin and Hippo-pathway readouts for APC-mutant colorectal cancer and hepatocellular carcinoma research.

• EDC.HCl Technical Workflow Guide

  2026-08-21

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation in peptide synthesis, bioconjugation, and related in vitro workflows. It should be handled as a freshly prepared laboratory reagent, not as an in vivo or clinical product, because the supplied dossier reports no in vivo or clinical data.

• 5X Protein Loading Buffer (Reducing): SDS-PAGE Guide

  2026-08-20

  5X Protein Loading Buffer (Reducing) supports denaturing, reducing protein sample preparation before conventional SDS-PAGE electrophoresis, helping reduce disulfide-linked assemblies and improve protein molecular weight separation. It is intended for reducing SDS-PAGE workflows and should not be used when native structure, enzymatic activity, or non-reducing disulfide patterns must be preserved.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-08-20

  Build a sensitive, repeatable Western blot workflow for low-abundance targets using HRP chemiluminescence, optimized membrane handling, antibody dilution, and exposure control. The guide connects the kit’s extended detection window with practical protein assays inspired by recent Alzheimer’s disease and oxidative-stress research.

• Recombinant Mouse IFN-γ in MASH-HCC Assays

  2026-08-19

  Recombinant Mouse IFN-γ provides a controlled functional challenge for testing whether metabolically stressed tumor cells can still execute antigen-presentation programs. This workflow guide connects Interferon gamma biology with bile acid–driven immune escape, antiviral validation, macrophage activation, and T-cell assay design.

• Nadolol (SQ-11725) for PK and Cardiovascular Research

  2026-08-19

  Nadolol (SQ-11725) combines non-selective beta-adrenergic blockade with transporter-relevant pharmacokinetics, making it useful for receptor signaling, vascular-response, and exposure-distribution workflows. This guide translates disease-state PK findings into practical assay design, sample handling, and troubleshooting strategies.

• Verteporfin and the Mechanics of Chemoresistance

  2026-08-18

  Verteporfin, also known as CL 318952, is more than a photosensitizer. Its light-dependent vascular and cytotoxic activity, together with light-independent p62 modulation, makes it a useful translational probe for connecting photodynamic therapy, autophagy, cell death, and the mechanical biology of chemoresistance.

• PR-619: DUB Inhibition for Interpretable Cell Assays

  2026-08-18

  PR-619 is a reversible deubiquitylating enzymes inhibitor for dissecting ubiquitin signaling without directly blocking proteasomal catalysis. This guide develops an assay-centered framework linking target breadth, autophagy interpretation, cancer biology research, and neurodegenerative disease models.

• Tankyrase Inhibitors, Hippo Signaling, and HCC

  2026-08-17

  The 2017 PLOS ONE study by Jia et al. showed that XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity through stabilization of AMOTL1 and AMOTL2. Its main innovation was to connect tankyrase inhibition with Hippo pathway regulation, extending the mechanistic relevance of tankyrases beyond Wnt/β-catenin signaling.

• Rimonabant (SR141716) in CB1 Research Workflows

  2026-08-17

  Rimonabant (SR141716) is a selective CB1 antagonist for separating receptor-driven effects from nonspecific behavioral, metabolic, and cellular responses. This workflow-focused guide shows how to apply it in withdrawal, appetite regulation, inflammation, and cell-based assays while controlling for sex, timing, formulation, and locomotor confounds.

• Vernakalant Phase 3 Trial: Rapid AF Conversion

  2026-08-16

  This phase 3 randomized trial showed that intravenous RSD1235, or vernakalant hydrochloride, converted short-duration atrial fibrillation to sinus rhythm substantially more often and more rapidly than placebo. Its stratified design and clinically relevant infusion protocol provide a useful framework for evaluating atrial-selective antiarrhythmic therapy while also illustrating the limits of short-term conversion endpoints.

8298 records 1/554 page Next 12345 下5页 Last page